BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 21877904)

  • 1. The dysregulation of cytokine networks in systemic lupus erythematosus.
    Apostolidis SA; Lieberman LA; Kis-Toth K; Crispín JC; Tsokos GC
    J Interferon Cytokine Res; 2011 Oct; 31(10):769-79. PubMed ID: 21877904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity.
    Moulton VR; Tsokos GC
    J Clin Invest; 2015 Jun; 125(6):2220-7. PubMed ID: 25961450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High salt diet accelerates the progression of murine lupus through dendritic cells via the p38 MAPK and STAT1 signaling pathways.
    Xiao ZX; Hu X; Zhang X; Chen Z; Wang J; Jin K; Cao FL; Sun B; Bellanti JA; Olsen N; Zheng SG
    Signal Transduct Target Ther; 2020 Apr; 5(1):34. PubMed ID: 32296043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of systemic lupus erythematosus.
    Childs SG
    Orthop Nurs; 2006; 25(2):140-5; quiz 146-7. PubMed ID: 16572034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epigenetic face of lupus: Focus on antigen-presenting cells.
    Wardowska A
    Int Immunopharmacol; 2020 Apr; 81():106262. PubMed ID: 32045873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus.
    Ding D; Mehta H; McCune WJ; Kaplan MJ
    J Immunol; 2006 Nov; 177(9):5878-89. PubMed ID: 17056512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunological basis of B-cell therapy in systemic lupus erythematosus.
    Mok MY
    Int J Rheum Dis; 2010 Feb; 13(1):3-11. PubMed ID: 20374380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T- and B-cell abnormalities in systemic lupus erythematosus.
    Nagy G; Koncz A; Perl A
    Crit Rev Immunol; 2005; 25(2):123-40. PubMed ID: 15952933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
    Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
    Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus.
    Bolouri N; Akhtari M; Farhadi E; Mansouri R; Faezi ST; Jamshidi A; Mahmoudi M
    Inflamm Res; 2022 Jun; 71(5-6):537-554. PubMed ID: 35298669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune cells and cytokines in systemic lupus erythematosus: an update.
    Kyttaris VC; Juang YT; Tsokos GC
    Curr Opin Rheumatol; 2005 Sep; 17(5):518-22. PubMed ID: 16093827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines in systemic lupus erythematosus.
    Lourenço EV; La Cava A
    Curr Mol Med; 2009 Apr; 9(3):242-54. PubMed ID: 19355907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients.
    García-Cózar FJ; Molina IJ; Cuadrado MJ; Marubayashi M; Peña J; Santamaría M
    Clin Exp Immunol; 1996 Apr; 104(1):72-9. PubMed ID: 8603537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective.
    Moulton VR; Suarez-Fueyo A; Meidan E; Li H; Mizui M; Tsokos GC
    Trends Mol Med; 2017 Jul; 23(7):615-635. PubMed ID: 28623084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine networks in systemic lupus erythematosus.
    Lee HM; Sugino H; Nishimoto N
    J Biomed Biotechnol; 2010; 2010():676284. PubMed ID: 20414360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus.
    Davis LS; Hutcheson J; Mohan C
    J Interferon Cytokine Res; 2011 Oct; 31(10):781-9. PubMed ID: 21787222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell abnormalities in systemic lupus erythematosus.
    Takeuchi T; Tsuzaka K; Abe T; Yoshimoto K; Shiraishi K; Kameda H; Amano K
    Autoimmunity; 2005 Aug; 38(5):339-46. PubMed ID: 16227148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do cytokines play a role in systemic lupus erythematosus?
    Singh AK
    J R Coll Physicians Lond; 1992 Oct; 26(4):374-6. PubMed ID: 1432876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities of T cell signaling in systemic lupus erythematosus.
    Moulton VR; Tsokos GC
    Arthritis Res Ther; 2011 Mar; 13(2):207. PubMed ID: 21457530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.